Sponsors

Bio-Rad expands QC range for Abbott diagnostic platforms

Bio-Rad Laboratories has announced an expanded portfolio of independent quality controls (QC) products, now including InteliQ and Liquichek compact vials, for the Abbott Alinity ci-series integrated clinical chemistry and immunoassay testing instruments.

"We are pleased to expand our offering of independent quality controls for the Abbott Alinity ci-series platforms,” said Dara Wright, EVP, and President of Bio-Rad’s Clinical Diagnostics Group. “Bio-Rad’s barcoded tubes and vials, combined with robust data management software, offer a flexible QC solution for a complete customer choice on Abbott Alinity ci platforms to streamline their QC workflow and enhance user experience.”

Bio-Rad is a leader in quality control products, offering an extensive range, covering analytes for immunoassay, chemistry, cardiac assessment, immunology, diabetes, coagulation, haematology, blood gas, drugs-of-abuse, and infectious disease testing. The company’s QC data management solutions connect large peer groups of test systems and assay methods to the company’s Unity Interlaboratory Program, enabling labs to compare their results in real time with over 29,000 other labs worldwide.

To learn more about Bio-Rad’s complete QC workflow solutions, please visit: http://www.qcnet.com/Abbott.

 

Latest Issues

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025

37th European Congress of Pathology

ACV, Vienna, Austria
6 -10 September, 2025